|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.36B 105B 1.19B 1.09B 1.02B 1.93B 129B 1.95B 13.08B 5.08B 63.4B 5.09B 4.98B 219B | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 162B 1.83B 1.68B 1.57B 2.97B 199B 3.01B 20.18B 7.84B 97.82B 7.86B 7.68B 338B | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 2013-12-31 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Gorelik
BRD | Director/Board Member | 47 | 2006-12-31 |
| Director/Board Member | 46 | 2012-12-31 | |
Dmitriy Genkin
CHM | Chairman | 57 | 2004-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 25.27M | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | |
| +3.86% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +2.80% | +39.13% | +28.20% | 301B | |
| -0.08% | +1.52% | +29.96% | +42.13% | 292B | |
| -1.54% | +3.56% | -25.96% | -40.53% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +2.90% | +5.44% | +27.99% | +50.50% | 369.97B | |
| Weighted average by Cap. | +2.24% | +5.54% | +41.79% | +80.52% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 438M 33.88B 383M 352M 328M 622M 41.73B 632M 4.23B 1.64B 20.49B 1.65B 1.61B 70.72B | 380M 29.34B 332M 305M 284M 539M 36.14B 547M 3.66B 1.42B 17.75B 1.43B 1.39B 61.25B |
| Net income | -698M -53.91B -610M -560M -523M -990M -66.41B -1.01B -6.73B -2.61B -32.61B -2.62B -2.56B -113B | -207M -16.04B -181M -167M -155M -295M -19.75B -299M -2B -778M -9.7B -779M -762M -33.48B |
| Net Debt | 693M 53.55B 606M 556M 519M 984M 65.96B 998M 6.68B 2.6B 32.4B 2.6B 2.54B 112B | 736M 56.9B 644M 591M 552M 1.05B 70.09B 1.06B 7.1B 2.76B 34.42B 2.76B 2.7B 119B |
Employees
60
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
